The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParity Regulatory News (PTY)

Share Price Information for Parity (PTY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.875
Bid: 0.85
Ask: 0.90
Change: 0.00 (0.00%)
Spread: 0.05 (5.882%)
Open: 0.875
High: 0.875
Low: 0.875
Prev. Close: 0.875
PTY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Jul 2022 07:00

RNS Number : 5244T
Parity Group PLC
25 July 2022
 

25 July 2022

 

Parity Group plc

 

Half Year Trading Update

 

Parity reports growth in net fee income for the first time in more than three years and a positive Adjusted EBITDA for H1 2022

 

 

Parity Group plc (AIM: PTY), the data and technology-focused recruitment and professional services company, is pleased to issue a trading update for the half year ended 30 June 2022.

 

H1 Highlights

· Net Fee Income expected to be up to 9% higher against prior period, H2 2021.

· The first time in more than three years that the business has increased NFI in sequential reporting periods.

· Improved operating performance in H1 2022 following actions taken to refocus the business and streamline the cost base during the prior year.

· Adjusted EBITDA(1) forecast for H1 2022 to be circa £0.3m, following an EBITDA(1) loss in H2 2021.

 

Mark Braund, Executive Chairman, said:

"Having successfully rebuilt the core recruitment business platform within Parity, we are beginning to see this capability make a positive impact on the performance of the business.

During the period, we materially improved customer relationships and the size and quality of Parity's virtual bench of skilled technology contractors, re-establishing it as one of the best of its kind addressing the public sector market. With improvements in mobility and skills transfer, Parity's access to these skilled resources will be increasingly valuable as we focus more of our attention on the commercial (private) sector.

With this foundation in place, we are evolving our proposition to include relevant new areas of business that will support future growth. Permanent recruitment is one such opportunity, driven by demand from current clients and the wider market. I am delighted that the investment we have made during H1 2022 to develop our permanent recruitment team is already beginning to pay back with a positive contribution to our first half performance. We are seeking to develop this revenue stream further in the second half.

The last nine months or so have seen significant change in the make-up, focus and strength of the team. The enthusiasm, commitment and tenacity of all my colleagues is at the core of Parity's turnaround. For this and on behalf of the Board, I say a heartfelt "thank you".

We still have much more to do but with each step we are making, our foundations are getting stronger. The balance of the year will be focused on maintaining our positive momentum and positioning the business for further growth in 2023."

(1) - Adjusted to exclude non underlying items

 

Contacts

Parity Group plc

Tel: + 44 (0) 20 8171 1729

Mark Braund, Executive Chairman

www.parity.net

Mike Johns, Chief Financial Officer

Allenby Capital Limited (Nominated Adviser and Broker)

Tel: +44 (0) 20 3328 5656

David Hart / Freddie Wooding (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRIMJTMTJTBMT
Date   Source Headline
15th Apr 20247:00 amRNSHolding(s) in Company
5th Apr 20243:41 pmRNSHolding(s) in Company
13th Mar 20245:59 pmRNSHolding(s) in Company
13th Mar 20245:00 pmRNSReceipt of Final Consideration
1st Feb 20243:10 pmRNSHolding(s) in Company
25th Jan 20247:00 amRNSHolding(s) in Company
19th Dec 202310:59 amRNSHolding(s) in Company
8th Dec 20232:31 pmRNSCompletion of Disposal, Change of Name & Website
7th Dec 20235:07 pmRNSResult of General Meeting
21st Nov 20232:43 pmRNSProposed disposal of PPL and notice of GM
29th Sep 20237:00 amRNSInterim Results
4th Aug 20237:00 amRNSTrading Statement
15th Jun 20234:05 pmRNSResult of AGM
15th Jun 20237:00 amRNSAGM Statement
22nd May 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
16th May 20237:00 amRNSFinal Results
26th Jan 20237:00 amRNSDirectorate Change
26th Jan 20237:00 amRNSTrading Update
30th Dec 20227:00 amRNSSale and Licence of Trademark
29th Sep 20227:00 amRNSInterim Results
25th Jul 20227:00 amRNSTrading Update
20th Jun 20222:20 pmRNSHolding(s) in Company
8th Jun 20221:24 pmRNSResult of AGM
8th Jun 20227:00 amRNSAGM Statement
16th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
12th May 20227:00 amRNSChange of Adviser
9th May 20227:00 amRNSDirector Dealing
27th Apr 20227:00 amRNSFinal Results
20th Jan 20227:00 amRNSTrading Update
4th Nov 20217:00 amRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSContract award
4th Oct 20217:00 amRNSGrant of Warrants and Options to Directors/PDMRs
22nd Sep 20218:41 amRNSInvestor Presentation
22nd Sep 20217:00 amRNSInterim Results
26th Aug 202110:40 amRNSTrading Update
24th Jun 202112:00 pmRNSIssue of Equity, Option Grant & Director Shares
10th Jun 202112:15 pmRNSResult of AGM
9th Jun 20212:40 pmRNSDirectorate Change
18th May 202111:18 amRNSNotice of AGM and Posting of Accounts
4th May 20219:50 amRNSHolding(s) in Company
21st Apr 20217:00 amRNSDirectorate Change
21st Apr 20217:00 amRNSFinal Results
12th Apr 20217:00 amRNSChange of Adviser
1st Mar 20217:00 amRNSNew contract wins and Notice of Results
1st Feb 20217:00 amRNSContract win
28th Jan 20217:00 amRNSTrading Statement
25th Nov 20207:00 amRNSDirector/PDMR Shareholding - Options Grant
22nd Sep 20207:00 amRNSInterim results
3rd Sep 20207:00 amRNSFramework Agreement and Notice of Interim Results
27th Aug 202011:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.